Mobile app reveals price differences of Rxs across local pharmacies
SALT LAKE CITY — Pharmacy customers looking to view and compare prescription drug prices now can do so on their iPhone or Android device.
LowestMed said its mobile application includes more than 1,000 of the most popular brand-name and generic drugs, consisting of more than 95% of the most commonly prescribed drugs in the nation, with thousands of additional drug price comparisons available on the company’s website LowestMed.com. How it works: LowestMed provides a list of discounted prices at nearby pharmacies of both branded prescription drugs and their generic alternatives. The app also includes access to the free LowestMed discount card, which when displayed at the point of sale, ensures savings of 10% to 85% off of retail prices, the company said.
“Most consumers don’t realize that prices can vary widely by pharmacy, and that up until this point the only way to do price comparisons on a local level was to go to each pharmacy and submit an insurance claim,” LowestMed CEO Brad Bangerter said. “With the LowestMed app, for the first time consumers are empowered with the full transparency to identify the least expensive drug prices in their area. We do for the pharmacy marketplace what Travelocity or Kayak does for the travel industry, providing a one-stop, fast, convenient and easy way for consumers to maximize savings on their medications.”
No comments found
Study: Gardasil doesn’t cause autoimmune conditions
PASADENA, Calif. — A human papillomavirus vaccine created by drug maker Merck does not cause autoimmune conditions after young women are inoculated, according to a new Kaiser Permanente study.
Researchers used electronic health records to conduct an observational safety study of 189,629 females ages 9 to 26 years in California who were followed for six months after receiving each dose of Gardasil, the quadrivalent HPV vaccine, from 2006 to 2008. The study looked for autoimmune conditions — such as immune thrombocytopenia, autoimmune hemolytic anemia, systemic lupus erythematosus, rheumatoid arthritis, juvenile rheumatoid arthritis, Type 1 diabetes, Hashimoto’s disease, Graves’ disease, multiple sclerosis, acute disseminated encephalomyelitis, other demyelinating diseases of the central nervous system, vaccine-associated demyelination, Guillain-Barre syndrome, neuromyelitis optica, optic neuritis and uveitis — since autoimmune reactions have been a long-standing concern surrounding vaccination and many parents withhold the vaccine from their children because of perceived safety concerns, the researchers noted.
"This kind of safety information may help parents with vaccination decisions," said study lead author Chun Chao, a research scientist at the Kaiser Permanente Department of Research & Evaluation in Pasadena, Calif. "These findings offer some assurance that among a large and generalizable female population, no safety signal for autoimmune conditions was found following HPV4 vaccination in routine clinical use."
The study, funded by Merck, appears in the Journal of Internal Medicine.
No comments found
FDA approves actinic keratosis treatment
PARSIPPANY, N.J. — The Food and Drug Administration has approved a topical treatment made by Leo Pharma for a skin condition that can lead to cancer, the drug maker said Wednesday.
Leo announced the FDA approval of Picato (ingenol mebutate) gel in the 0.015%/0.05% strength for actinic keratosis, also known as AK, which is a precancerous condition resulting from cumulative sun exposure that has the potential to lead to squamous cell carcinoma.
"Since there is no way to predict which actinic keratosis will advance to skin cancer, early detection and treatment of lesions are critical," said Mark Lebwohl of the Department of Dermatology at New York’s Mount Sinai Medical Center and an investigator of a late-stage clinical trial of the drug. "What makes this new solution particularly exciting is the two- or three-day course of treatment."
According to the American Academy of Dermatology, 1-in-5 Americans will develop skin cancer in their lifetimes, and studies have shown that about 65% of cases of squamous cell carcinoma begin as untreated actinic keratosis.
A creamy avocado makes a surprise appearance in this sweet breakfast beverage. At just 249 calories per serving, this smoothie will give you the energy you need to start the day without a calorie overload. Phoenix food delivery
Thanks for some other informative website. The place else may I am getting that kind of info written in such a perfect method? I have a challenge that I am just now operating on,and I’ve been on the look out for such info.dwi lawyer new braunfels
Valuable in order and superb design you got at this juncture! I would like to thank you in favor of sharing your belief and point in time into the stuff you place of duty!! truck value
I agree- lasers do not sound like a good way to treat sun related problems. But I could be wrong. Austin homes
The way the post describe the whole thing is interesting. following the information the writing was coherent.the information will help me a lot also.folding guest beds
silicone halloween masks for sale I really appreciate your post.It gives an outstanding idea that is very helpful for all the people on the web. Thanks for sharing this information and I'll love to read your next post too.
Very nice article, I enjoyed reading your post, very nice share, I want to twit this to my followers. Thanks!. Happy Wheels
As FDA approved actinic keratosis treatment then it would be better on skin condition and also helpful in preventing skin cancer. Regards, Irvine
Yeah.. I thought it was another acne scam medication but when my friend tried it. It really did worked.. In just less than 2weeks, he can barely see good result.. -hadwin patrise
The sun isn't the only thing that causes actinic keratosis.Facial laser treatments such as laser resurfacing and just about any other laser treatment will cause this. The heat from these lasers is more stronger than the sun and will cause extensive damage far below the surface of the skin.I think FDA had to tasted this before approved it.